1. HOME
2. Research Insight
3. Abbott Laboratories, Inc. (US) and GE Healthcare (US) are Leading Players in the Intracardiac Echocardiography (ICE) Market

The intracardiac echocardiography (ICE) market is projected to reach USD 545 million by 2029 from USD 333 million in 2024, growing at a CAGR of 10.3% during the forecast period. The globally increasing aged population, rising rate of cardiovascular disorders due to lifestyle changes, and other considerations primarily drivers of the growth in intracardiac echocardiography market. These systems are now more effective and efficient to use due to continuous advancements in ICE technology, including improved imaging capacity and Al integration, as well as growing spending in healthcare facilities.

The intracardiac echocardiography (ICE) market is considered by a adequate degree of competition, with a few well-established competitors controlling a adequate portion of the market share. The market is more aggressive because the diagnostic technologies are in great demand due to the rising incidence of heart diseases. Some of the key players in the intracardiac echocardiography (ICE) market: Medtronic plc (Ireland), GE Healthcare (US), Abbott Laboratories, Inc. (US), Siemens Healthineers (Germany) and Mindray Medical International. (China), Boston Scientific Corporation (US) are the significant companies in the intracardiac echocardiography (ICE) market.

To know about the assumptions considered for the study download the pdf brochure

Abbott Laboratories (US): Abbott Laboratories offers the most known intracardiac echocardiography technologies, including the ViewFlex Xtra ICE Catheter and the ViewMate Ultrasound Console. They have been leading products offered by this company aimed at providing real-time high-quality heart design visualization during interventional treatments. Real-time images are provided by ICE technology, which is used to guide a range of treatments from catheter ablations to electrophysiological tests and device closures. The detailed images provided by the ViewMate Ultrasound Console allow it to guide a myriad of cardiac treatments accurately. Less invasive operations can be executed using ICE, which is possible to potentially bring down more invasive techniques and hence reduce the risk associated with such consequences. Abbott ICE solutions are hence vital in modern cardiology since it brings improved results, more safety, and effectiveness of interventional cardiac operations.

GE Healthcare (US): Within the intracardiac echocardiography (ICE) sector, GE Healthcare, a well-established pioneer in medical technology, has an array of experience. Vivid series cardiovascular ultrasound devices from GE Healthcare offer sophisticated intracardiac echocardiography (ICE) solutions. Vivid Ultra Edition devices improve clinical efficiency by providing uncompromising picture quality, sophisticated visualisation, simple measurements, and workflow automation. A key component of GE Healthcare's cardiovascular imaging portfolio is its intracardiac echocardiography (ICE) division, which offers cutting-edge ultrasound devices made for high-resolution, real-time visualisation of cardiac structures. The Vivid S Series, which is well-known for its lightweight and portable form, has an easy-to-use interface and ergonomic design that make it suitable for a variety of clinical situations. With the addition of Artificial Intelligence, GE Healthcare has improved the capacity of its Venue Ultrasound Systems to produce cardiac pictures automatically and expedite diagnostic procedures. This invention exemplifies GE's dedication to using state-of-the-art technology to enhance patient outcomes. All things considered, the ICE systems from GE Healthcare are made to provide cardiologists and interventionalists with superior imaging options that improve clinical judgement and patient care.

Medtronic plc (Ireland): Intracardiac echocardiography (ICE) technology from Medtronic is a key component of cardiac imaging because it allows for real-time, high-resolution visualisation of cardiac structures, which is necessary for a number of interventional treatments. Better imaging and navigation during procedures are made possible by Medtronic's steerable sheath (FlexCath), which improves the accuracy and manoeuvrability of ICE catheters. Utilising Medtronic's steerable sheath, the ViewFlex ICE catheter was created by St. Jude Medical, which is now a part of Abbott. Detailed views of cardiac structures are provided by this catheter, which makes intricate procedures like ablations easier to complete. When it comes to atrial fibrillation ablation operations, Medtronic's ICE technology is very important since it provides real-time imaging to enhance accuracy and results. Clinicians can get comprehensive guidelines to ensure safety and effectiveness.

Philips Healthcare (Netherlands): With its 3D ICE catheters, in particular, Philips has achieved notable strides in intracardiac echocardiography (ICE) technology, and the company has a strong portfolio overall. A state-of-the-art 3D ICE catheter with a 9 French system and an 840-element matrix array is the Philips VeriSight Pro. It offers 3D imaging in real time, improving the precision and effectiveness of minimally invasive cardiac operations. Philips has recently launched the VeriSight Pro in Hong Kong, expanding worldwide access to their 3D ICE technology. The goal of this expansion is to give medical practitioners cutting-edge instruments to improve patient outcomes and procedural precision. Through the provision of high-quality imaging and real-time guidance, which improves the accuracy and safety of cardiac treatments, Philips' advances in ICE technology are revolutionising cardiac care.

Siemens Healthineers (Germany): Siemens Healthineers is a leader in intracardiac echocardiography (ICE) technology, providing cutting-edge approaches to improve cardiac care. Over the years, Siemens Healthineers has made significant advancements in cardiac imaging and intervention techniques through its long history of innovation in ICE. With accurate anatomical visualisation during cardiac procedures, Siemens' ICE technology provides high-resolution imaging that improves procedural efficiency and patient outcomes. The ACUSON P500 ICE System helps medical practitioners provide superior cardiac care by providing extensive training and cutting-edge imaging capabilities.    With their comprehensive and real-time visualisation that improves the accuracy and safety of cardiac treatments, Siemens Healthineers' ICE solutions continue to establish new benchmarks in cardiac imaging.

Related Reports:

Intracardiac Echocardiography (ICE) Market by Product (Ultrasound (2D, 3D/4D, Doppler), Catheter, Console, Software), Application (Valve Defects, Electrophysiology, Monitoring), Enduser (Hospital, ASC, Diagnostic Centers) & Region Global Forecasts to 2029

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]